Back to Search Start Over

Devices for Distal Protection During Percutaneous Coronary Revascularization

Authors :
Campbell Rogers
Donald S. Baim
Laura Mauri
Source :
Circulation. 113:2651-2656
Publication Year :
2006
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2006.

Abstract

Despite early perceptions that distal embolization of atherosclerotic plaque contents was a rare event during balloon angioplasty, it has now become clear that manipulation of atherosclerotic lesions with wires, balloons, atherectomy catheters, or stents does liberate plaque debris. The tendency of this liberated debris to cause clinical manifestations depends on the amount of debris, the size of particles, and the sensitivity of the perfused organ. Additionally, clinical experience with various embolic protection devices (EPDs) has shown that the capture and retrieval of potentially embolic debris reduce adverse events in situations where the amount of debris is largest (eg, saphenous vein grafts [SVGs]) and where the end organ is most sensitive (myocardium, with no reflow and creatine kinase [CK]-MB release; brain with new lesions on magnetic resonance imaging or clinical stroke). In contrast, other adjunctive medical therapies such as glycoprotein IIb/IIIa receptor antagonists, which have been shown to reduce overall rates of CK-MB release during other coronary interventional procedures, have failed to mitigate the impact of distal embolization in SVG intervention.1–3 Embolic protection is thus now firmly established as a routine component of SVG and carotid stenting, although randomized trials have not been performed for the latter indication.4,5 Although it is almost certain that atherosclerotic or atherothrombotic debris is released during other interventions on peripheral, renal, and native coronary arteries, the link between such embolization and clinical events (and hence the rationale for embolic protection) has been more difficult to demonstrate. This may be due to smaller amounts of embolic debris, less sensitive metrics of end-organ damage, or less complete capture of debris by devices tested to date in those locales. For example, initial trials of distal embolic protection in native coronaries during primary angioplasty for acute myocardial infarction have shown retrieval of smaller amounts of debris than seen …

Details

ISSN :
15244539 and 00097322
Volume :
113
Database :
OpenAIRE
Journal :
Circulation
Accession number :
edsair.doi.dedup.....ac680eadd55c7a611d162ded786fde05